CoChat
Sign Up
Cited by 1,082Cystic Fibrosis Research AdvancesNeonatal Respiratory Health ResearchTissue Engineering and Regenerative Medicine

The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.

Long‐term expanding human airway organoids for disease modeling

Open access
Sachs, Norman, Papaspyropoulos, Angelos, Zomer‐van Ommen, Domenique D, Heo, Inha, Böttinger, Lena, Klay, Dymph, Weeber, Fleur, Huelsz‐Prince, Guizela, Iakobachvili, Nino, Amatngalim, Gimano D, de Ligt, Joep, van Hoeck, Arne, Proost, Natalie, Viveen, Marco C, Lyubimova, Anna, Teeven, Luc, Derakhshan, Sepideh, Korving, Jeroen, Begthel, Harry, Dekkers, Johanna F, Kumawat, Kuldeep, Ramos, Emilio, van Oosterhout, Matthijs FM, Offerhaus, G Johan, Wiener, Dominique J, Olimpio, Eduardo P, Dijkstra, Krijn K, Smit, Egbert F, van der Linden, Maarten, Jaksani, Sridevi, van de Ven, Marieke, Jonkers, Jos, Rios, Anne C, Voest, Emile E, van Moorsel, Coline HM, van der Ent, Cornelis K, Cuppen, Edwin, van Oudenaarden, Alexander, Coenjaerts, Frank E, Meyaard, Linde, Bont, Louis J, Peters, Peter J, Tans, Sander J, van Zon, Jeroen S, Boj, Sylvia F, Vries, Robert G, Beekman, Jeffrey M, Clevers, Hans·2019·The EMBO Journal
DOI 10.15252/embj.2018100300PMC PMC6376275

Published version of a preprint

Open this paper in CoChat — free accountOpen PDF

Abstract

Abstract Organoids are self-organizing 3D structures grown from stem cells that recapitulate essential aspects of organ structure and function. Here we describe a method to establish long-term-expanding human airway organoids from broncho-alveolar biopsies or lavage material. The pseudostratified airway organoid epithelium consists of basal cells, functional multi-ciliated cells, mucus-producing goblet cells, and CC10-secreting club cells. Airway organoids derived from cystic fibrosis (CF) patients allow assessment of CFTR function in an organoid swelling assay. Organoid culture conditions also allow gene editing as well as the derivation of various types of lung cancer organoids. Respiratory syncytial virus (RSV) infection recapitulated central disease features and dramatically increases organoid cell motility, found to be driven by the non-structural viral NS2 protein. We conclude that human airway organoids represent versatile models for the in vitro study of hereditary, malignant, and infectious pulmonary disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.15252/embj.2018100300

Cites

82 of 82 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Characterization of airway organoids Transmission electron micrograph of an AO cross section showing the polarized, pseudostratified epithelium containing basal, secretory, brush, and multi‐ciliated cells. Details display apical microvilli and cilia with their characteristic microtubule structure. Scale bars equal 10 μm, 2 μm, and 500 nm. See also Appendix Fig S1A and [Link], [Link], [Link].Scanning electron micrograph of a partially opened AO visualizing its 3D architecture, as well as basal and apical ultrastructure. Details display apical surfaces of secretory and multi‐ciliated cells. Scale bars equal 50 μm (overview) and 2 μm (details).Immunofluorescent sections of AOs showing markers for basal cells (KRT5), cilia (acetylated α‐tubulin), secretory cells (MUC5AC), and club cells (SCGB1A1). KRT5 is present exclusively in basally localized cells, while cilia, MUC5AC, and SCGB1A1 localize luminally. Counterstained is the actin cytoskeleton (red). Scale bar equals 10 μm. See Appendix Fig S1B for IHC images.Luminescent cell viability assay comparing proliferative capacity of two independently generated AO lines at early, mid‐, and late passage numbers. Per group, 3,000 cells were seeded and their expansion was measured at the indicated time points. Error bars represent standard deviations of technical triplicates.Quantification of cell types in AO lines at early and late passage (P5 vs. P19) as determined by immunofluorescence using the indicated markers. The number of basal cells, club cells, ciliated cells, and secretory cells does not differ significantly between early and late passage AOs. Data shown are representatives of at least three independent experiments. Error bars indicate s.e.m.
Figure 1 Characterization of airway organoids Transmission electron micrograph of an AO cross section showing the polarized, pseudostratified epithelium containing basal, secretory, brush, and multi‐ciliated cells. Details display apical microvilli and cilia with their characteristic microtubule structure. Scale bars equal 10 μm, 2 μm, and 500 nm. See also Appendix Fig S1A and [Link], [Link], [Link].Scanning electron micrograph of a partially opened AO visualizing its 3D architecture, as well as basal and apical ultrastructure. Details display apical surfaces of secretory and multi‐ciliated cells. Scale bars equal 50 μm (overview) and 2 μm (details).Immunofluorescent sections of AOs showing markers for basal cells (KRT5), cilia (acetylated α‐tubulin), secretory cells (MUC5AC), and club cells (SCGB1A1). KRT5 is present exclusively in basally localized cells, while cilia, MUC5AC, and SCGB1A1 localize luminally. Counterstained is the actin cytoskeleton (red). Scale bar equals 10 μm. See Appendix Fig S1B for IHC images.Luminescent cell viability assay comparing proliferative capacity of two independently generated AO lines at early, mid‐, and late passage numbers. Per group, 3,000 cells were seeded and their expansion was measured at the indicated time points. Error bars represent standard deviations of technical triplicates.Quantification of cell types in AO lines at early and late passage (P5 vs. P19) as determined by immunofluorescence using the indicated markers. The number of basal cells, club cells, ciliated cells, and secretory cells does not differ significantly between early and late passage AOs. Data shown are representatives of at least three independent experiments. Error bars indicate s.e.m.CC BY-NC-ND · PubMed Central
Figure 2 Airway organoids to study cystic fibrosis Box‐and‐whisker plot showing concentration‐dependent forskolin‐induced swelling of AOs in the absence and presence of CFTR inhibitors CFTRinh‐172 and GlyH101. Upon CFTR inhibition, swelling is noticeably decreased but not absent. Shown are pooled data from three different AO lines used in each of three independent experiments. Whiskers indicate smallest and largest values, boxes indicate 25th to 75th percentile, and horizontal solid line indicates median. AUC, area under the curve.Box‐and‐whisker plot showing concentration‐dependent Eact‐induced swelling of AOs, but not rectal organoids (black outlines). Forskolin causes swelling in both organoid types (gray outlines). Shown are pooled data from three different AO and two different rectal organoid lines used in three to four independent experiments. Whiskers indicate smallest and largest values, boxes indicate 25th to 75th percentile, and horizontal solid line indicates median. Swelling was linear for 2 h for AOs, but only 1 h for rectal organoids. See Appendix Fig S3A for respective time course plots.Representative histological sections of periodic acid–Schiff (PAS)‐stained organoids from a CF patient with CFTR F508del/F508del mutation. Note the thick layer of PAS‐positive polysaccharides apically lining the airway epithelium. Rectal organoids were generated from rectal biopsies; AOs were generated from broncho‐alveolar lavages (BALs). Scale bars equal 50 μm. See Appendix Fig S3B for PAS‐stained wild‐type and CFTR R334W/R334W organoid sections.Box‐and‐whisker plot showing swelling assays of several CF patient AO lines carrying the indicated CFTR mutations (G542X is a premature stop associated with severe disease and no functional CFTR protein; F508del is the most common CFTR mutation in subjects with CF and severely reduces apical trafficking and function, leading to severe disease (high sweat chloride, high pancreas insufficiency, high pseudomonas infection rate); R334W is a milder CFTR mutation associated as indicated by lower pseudomonas infection rates and pancreas sufficiency with reduced ion channel conductivity, normal apical expression, and some residual function). Forskolin‐induced swelling rarely exceeds vehicle controls in CF AOs, but increases in the presence of the CFTR modulating drugs VX‐770 and VX‐809. Eact‐induced swelling exceeds forskolin‐induced swelling to a similar extent as pre‐treatment with VX‐770 and VX‐809 in four out of five CF AO lines. In contrast, BAL‐derived WT AOs swell following forskolin stimulation independent of the presence of VX‐770 and VX‐809. Of note, Eact‐induced swelling is not observed in this AO line. Shown are pooled data of four to five independent experiments (CF AOs) or two independent experiments (WT AOs). Whiskers indicate smallest and largest values, boxes indicate 25th to 75th percentile, and horizontal solid line indicates median. See Appendix Fig S3C for selected time course plots.Whole‐mounted immunofluorescence analysis of BAL AO‐derived ALI cultures. After 3 weeks of differentiation, ALI cultures show ciliated airway epithelium (green, β‐tubulin). Counterstained are the actin cytoskeleton (red) and nuclei (blue).Transepithelial electrical measurements of BAL AO‐derived ALI cultures. Shown are equivalent current (I eq) traces of a CFTR wt/wt (gray) and CFTR F508del/F508del donor, treated with vehicle (blue) or VX‐809 and VX‐770 (red). Inhibition of the epithelial sodium channel (ENaC) with benzamil was observed in all traces (declining I eq). Forskolin increased the current in CFTR wt/wt and CFTR F508del/F50del donor treated with VX‐809 and VX‐770, but not in the vehicle treated. A decline was observed with CFTRinh‐172 in all examined conditions. The bar graphs quantify the peak forskolin activated‐ and CFTRinh‐172 inhibited‐currents. Shown are pooled data of four independent measurements for each donor. Results are shown as mean ± s.d.
Figure 2 Airway organoids to study cystic fibrosis Box‐and‐whisker plot showing concentration‐dependent forskolin‐induced swelling of AOs in the absence and presence of CFTR inhibitors CFTRinh‐172 and GlyH101. Upon CFTR inhibition, swelling is noticeably decreased but not absent. Shown are pooled data from three different AO lines used in each of three independent experiments. Whiskers indicate smallest and largest values, boxes indicate 25th to 75th percentile, and horizontal solid line indicates median. AUC, area under the curve.Box‐and‐whisker plot showing concentration‐dependent Eact‐induced swelling of AOs, but not rectal organoids (black outlines). Forskolin causes swelling in both organoid types (gray outlines). Shown are pooled data from three different AO and two different rectal organoid lines used in three to four independent experiments. Whiskers indicate smallest and largest values, boxes indicate 25th to 75th percentile, and horizontal solid line indicates median. Swelling was linear for 2 h for AOs, but only 1 h for rectal organoids. See Appendix Fig S3A for respective time course plots.Representative histological sections of periodic acid–Schiff (PAS)‐stained organoids from a CF patient with CFTR F508del/F508del mutation. Note the thick layer of PAS‐positive polysaccharides apically lining the airway epithelium. Rectal organoids were generated from rectal biopsies; AOs were generated from broncho‐alveolar lavages (BALs). Scale bars equal 50 μm. See Appendix Fig S3B for PAS‐stained wild‐type and CFTR R334W/R334W organoid sections.Box‐and‐whisker plot showing swelling assays of several CF patient AO lines carrying the indicated CFTR mutations (G542X is a premature stop associated with severe disease and no functional CFTR protein; F508del is the most common CFTR mutation in subjects with CF and severely reduces apical trafficking and function, leading to severe disease (high sweat chloride, high pancreas insufficiency, high pseudomonas infection rate); R334W is a milder CFTR mutation associated as indicated by lower pseudomonas infection rates and pancreas sufficiency with reduced ion channel conductivity, normal apical expression, and some residual function). Forskolin‐induced swelling rarely exceeds vehicle controls in CF AOs, but increases in the presence of the CFTR modulating drugs VX‐770 and VX‐809. Eact‐induced swelling exceeds forskolin‐induced swelling to a similar extent as pre‐treatment with VX‐770 and VX‐809 in four out of five CF AO lines. In contrast, BAL‐derived WT AOs swell following forskolin stimulation independent of the presence of VX‐770 and VX‐809. Of note, Eact‐induced swelling is not observed in this AO line. Shown are pooled data of four to five independent experiments (CF AOs) or two independent experiments (WT AOs). Whiskers indicate smallest and largest values, boxes indicate 25th to 75th percentile, and horizontal solid line indicates median. See Appendix Fig S3C for selected time course plots.Whole‐mounted immunofluorescence analysis of BAL AO‐derived ALI cultures. After 3 weeks of differentiation, ALI cultures show ciliated airway epithelium (green, β‐tubulin). Counterstained are the actin cytoskeleton (red) and nuclei (blue).Transepithelial electrical measurements of BAL AO‐derived ALI cultures. Shown are equivalent current (I eq) traces of a CFTR wt/wt (gray) and CFTR F508del/F508del donor, treated with vehicle (blue) or VX‐809 and VX‐770 (red). Inhibition of the epithelial sodium channel (ENaC) with benzamil was observed in all traces (declining I eq). Forskolin increased the current in CFTR wt/wt and CFTR F508del/F50del donor treated with VX‐809 and VX‐770, but not in the vehicle treated. A decline was observed with CFTRinh‐172 in all examined conditions. The bar graphs quantify the peak forskolin activated‐ and CFTRinh‐172 inhibited‐currents. Shown are pooled data of four independent measurements for each donor. Results are shown as mean ± s.d.CC BY-NC-ND · PubMed Central
Figure 3 Modeling lung cancer using airway organoids Tumor AOs derived from different resected primary lung cancer types recapitulate their respective histopathological features. Examples include adenocarcinoma (41T, white arrowheads: multiple nucleoli, black arrowheads: tubule formation), mucinous adenocarcinoma (42T/36T, arrowheads: mucinous glands, stars: PAS‐positive mucus), adenocarcinoma lepidic type (previously known as broncho‐alveolar carcinoma, 95T, arrowheads: distinct large nuclei), squamous cell carcinoma (65T, arrowheads: multi‐layered, keratinization), and large cell neuroendocrine tumor (46T, arrowheads: large nuclei, p53 immunolabeling). Scale bars equal 50 μm.Tumor AOs derived from metastatic adenocarcinomas give rise to lung cancer in vivo following intratracheal instillation into immunocompromised mice. 30% of injected mice (n = 12) developed visible tumors 8 weeks after instillation. Tumors show features of adenocarcinomas (HE stainings) and are integrated within murine stroma (human keratin immunolabeling). Scale bars equal 50 μm.WGS reveals largely conserved mutation status of lung cancer genes between matched tumor–organoid pairs (left plot, Appendix Table S1). The right plot shows mutation status of selected lung cancer genes in several additional tumor AO lines derived from primary as well as metastatic lung cancer. Of note, ERBB2 mutation frequencies in 52MET and 52MET II tumor AOs were almost identical (67 and 70%) despite originating from independent biopsies taken 3 months apart. See Appendix Table S2.Heat map of IC50 values of selected anti‐cancer drugs indicating differential responses of tumor AOs. For example, 46T (mutant TP53) is resistant to Nutlin‐3a treatment, 65T (mutant ALK1) is resistant to treatment with crizotinib, and 52MET (mutant ERBB2) is sensitive to treatment with erlotinib and gefitinib. See Appendix Fig S4F for individual dose–response curves.
Figure 3 Modeling lung cancer using airway organoids Tumor AOs derived from different resected primary lung cancer types recapitulate their respective histopathological features. Examples include adenocarcinoma (41T, white arrowheads: multiple nucleoli, black arrowheads: tubule formation), mucinous adenocarcinoma (42T/36T, arrowheads: mucinous glands, stars: PAS‐positive mucus), adenocarcinoma lepidic type (previously known as broncho‐alveolar carcinoma, 95T, arrowheads: distinct large nuclei), squamous cell carcinoma (65T, arrowheads: multi‐layered, keratinization), and large cell neuroendocrine tumor (46T, arrowheads: large nuclei, p53 immunolabeling). Scale bars equal 50 μm.Tumor AOs derived from metastatic adenocarcinomas give rise to lung cancer in vivo following intratracheal instillation into immunocompromised mice. 30% of injected mice (n = 12) developed visible tumors 8 weeks after instillation. Tumors show features of adenocarcinomas (HE stainings) and are integrated within murine stroma (human keratin immunolabeling). Scale bars equal 50 μm.WGS reveals largely conserved mutation status of lung cancer genes between matched tumor–organoid pairs (left plot, Appendix Table S1). The right plot shows mutation status of selected lung cancer genes in several additional tumor AO lines derived from primary as well as metastatic lung cancer. Of note, ERBB2 mutation frequencies in 52MET and 52MET II tumor AOs were almost identical (67 and 70%) despite originating from independent biopsies taken 3 months apart. See Appendix Table S2.Heat map of IC50 values of selected anti‐cancer drugs indicating differential responses of tumor AOs. For example, 46T (mutant TP53) is resistant to Nutlin‐3a treatment, 65T (mutant ALK1) is resistant to treatment with crizotinib, and 52MET (mutant ERBB2) is sensitive to treatment with erlotinib and gefitinib. See Appendix Fig S4F for individual dose–response curves.CC BY-NC-ND · PubMed Central
Figure 4 Modeling RSV infection with airway organoids Quantitative PCR showing RSV replication kinetics in the indicated AO lines.Representative phase‐contrast/GFP overlays of RSV‐infected AOs (5 days post‐infection). GFP signal is absent following pre‐incubation with palivizumab (fusion blocking antibody) but not control IgG. Scale bars equal 100 μm.Immunohistochemical RSV staining (top) and scanning electron micrograph (bottom) of RSV‐infected AOs (5 days post‐infection) show organoid fusion and blebbing. Scale bars equal 50 μm.3D reconstructions of immunolabeled AOs 3 days after RSV infection showing (clockwise) cytoskeletal rearrangements, apical extrusion of infected cells, syncytia formation, and organoid fusion. Scale bars equal 50 μm.RSV infection causes increased organoid velocity (Tukey boxplot) and organoid fusion (pie chart). Shown are data from three independent experiments. Horizontal solid line indicates median, box indicate 25th to 75th percentile, whiskers indicate 25th percentile minus 1.5 times inter‐quartile distance (IQR) or 75th percentile plus 1.5 times IQR, and circles indicate individual values greater than 1.5 times IQR. See also Movie EV4.Cells within RSV‐infected organoids are more motile than cells in control organoids irrespective of induced organoid rotation. Cell traces above individual Tukey boxplots are from representative organoids. Shown are data from two to three independent experiments. Horizontal solid line indicates median, box indicates 25th to 75th percentile, whiskers indicate 25th percentile minus 1.5 times inter‐quartile distance (IQR) or 75th percentile plus 1.5 times IQR, and circles indicate individual values greater than 1.5 times IQR. See also Appendix Fig S5A and B, and Movies EV5 and EV6.GSEA plots showing strong enrichment of indicated gene signatures in transcriptomes of four independently RSV‐ vs. mock‐infected AO lines. NES, normalized enrichment score. See Table EV4 for signatures and leading‐edge genes.Hierarchical clustering of the indicated AO lines displaying the 36 most differentially expressed genes of RSV‐ vs. mock‐infected AO transcripts as well as selected cytokines (see Table EV4). Gradients depict the relative maximum and minimum values per transcript. Names and ranks of selected genes involved in migration (KRT16, KRT6B), interferon signaling (IL1RN, IFI44L), and viral response (MX2, OAS1) are indicated.ELISA‐based quantification of cytokines secreted by mock‐ vs. RSV‐infected AOs. Shown are data from two independent experiments. Whiskers indicate smallest and largest values, boxes indicate 25th to 75th percentile, and horizontal solid line indicates median.Box‐and‐whisker plot showing increased numbers of primary human neutrophils populating RSV‐ compared to mock‐infected AOs. Shown are data from two independent experiments. Whiskers indicate smallest and largest values, boxes indicate 25th to 75th percentile, and horizontal solid line indicates median. See also Movies EV8 and EV9.Quantitative PCR showing replication kinetics of wild‐type (wt) and mutant RSV lacking NS2 (ΔNS2) in the indicated AO lines. See also Movie EV10.Inducible overexpression of NS2 causes increased organoid velocity (box‐and‐whisker plot) and fusion (pie chart). Shown are data from three independent experiments. Horizontal solid line indicates median, box indicates 25th to 75th percentile, whiskers indicate 25th percentile minus 1.5 times inter‐quartile distance (IQR) or 75th percentile plus 1.5 times IQR, and circles indicate individual values greater than 1.5 times IQR. See Appendix Fig S6, Movie EV11.
Figure 4 Modeling RSV infection with airway organoids Quantitative PCR showing RSV replication kinetics in the indicated AO lines.Representative phase‐contrast/GFP overlays of RSV‐infected AOs (5 days post‐infection). GFP signal is absent following pre‐incubation with palivizumab (fusion blocking antibody) but not control IgG. Scale bars equal 100 μm.Immunohistochemical RSV staining (top) and scanning electron micrograph (bottom) of RSV‐infected AOs (5 days post‐infection) show organoid fusion and blebbing. Scale bars equal 50 μm.3D reconstructions of immunolabeled AOs 3 days after RSV infection showing (clockwise) cytoskeletal rearrangements, apical extrusion of infected cells, syncytia formation, and organoid fusion. Scale bars equal 50 μm.RSV infection causes increased organoid velocity (Tukey boxplot) and organoid fusion (pie chart). Shown are data from three independent experiments. Horizontal solid line indicates median, box indicate 25th to 75th percentile, whiskers indicate 25th percentile minus 1.5 times inter‐quartile distance (IQR) or 75th percentile plus 1.5 times IQR, and circles indicate individual values greater than 1.5 times IQR. See also Movie EV4.Cells within RSV‐infected organoids are more motile than cells in control organoids irrespective of induced organoid rotation. Cell traces above individual Tukey boxplots are from representative organoids. Shown are data from two to three independent experiments. Horizontal solid line indicates median, box indicates 25th to 75th percentile, whiskers indicate 25th percentile minus 1.5 times inter‐quartile distance (IQR) or 75th percentile plus 1.5 times IQR, and circles indicate individual values greater than 1.5 times IQR. See also Appendix Fig S5A and B, and Movies EV5 and EV6.GSEA plots showing strong enrichment of indicated gene signatures in transcriptomes of four independently RSV‐ vs. mock‐infected AO lines. NES, normalized enrichment score. See Table EV4 for signatures and leading‐edge genes.Hierarchical clustering of the indicated AO lines displaying the 36 most differentially expressed genes of RSV‐ vs. mock‐infected AO transcripts as well as selected cytokines (see Table EV4). Gradients depict the relative maximum and minimum values per transcript. Names and ranks of selected genes involved in migration (KRT16, KRT6B), interferon signaling (IL1RN, IFI44L), and viral response (MX2, OAS1) are indicated.ELISA‐based quantification of cytokines secreted by mock‐ vs. RSV‐infected AOs. Shown are data from two independent experiments. Whiskers indicate smallest and largest values, boxes indicate 25th to 75th percentile, and horizontal solid line indicates median.Box‐and‐whisker plot showing increased numbers of primary human neutrophils populating RSV‐ compared to mock‐infected AOs. Shown are data from two independent experiments. Whiskers indicate smallest and largest values, boxes indicate 25th to 75th percentile, and horizontal solid line indicates median. See also Movies EV8 and EV9.Quantitative PCR showing replication kinetics of wild‐type (wt) and mutant RSV lacking NS2 (ΔNS2) in the indicated AO lines. See also Movie EV10.Inducible overexpression of NS2 causes increased organoid velocity (box‐and‐whisker plot) and fusion (pie chart). Shown are data from three independent experiments. Horizontal solid line indicates median, box indicates 25th to 75th percentile, whiskers indicate 25th percentile minus 1.5 times inter‐quartile distance (IQR) or 75th percentile plus 1.5 times IQR, and circles indicate individual values greater than 1.5 times IQR. See Appendix Fig S6, Movie EV11.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 82 references

Cited by

Sorted by citations

Items 201–300 of 1,000

Related

See all

Metadata

Authors
Sachs, N., Papaspyropoulos, A., Zomer‐van Ommen, D. D., Heo, I., Böttinger, L., Klay, D., Weeber, F., Huelsz‐Prince, G., Iakobachvili, N., Amatngalim, G. D., de Ligt, J., van Hoeck, A., Proost, N., Viveen, M. C., Lyubimova, A., Teeven, L., Derakhshan, S., Korving, J., Begthel, H., Dekkers, J. F., Kumawat, K., Ramos, E., van Oosterhout, M. F., Offerhaus, G. J., Wiener, D. J., Olimpio, E. P., Dijkstra, K. K., Smit, E. F., van der Linden, M., Jaksani, S., van de Ven, M., Jonkers, J., Rios, A. C., Voest, E. E., van Moorsel, C. H., van der Ent, C. K., Cuppen, E., van Oudenaarden, A., Coenjaerts, F. E., Meyaard, L., Bont, L. J., Peters, P. J., Tans, S. J., van Zon, J. S., Boj, S. F., Vries, R. G., Beekman, J. M., & Clevers, H.
Affiliations
  • University Medical Center Utrecht (NL)
  • St. Antonius Ziekenhuis (NL)
  • The Netherlands Cancer Institute (NL)
  • Institute for Atomic and Molecular Physics (NL)
  • Maastricht University (NL)
  • Hubrecht Institute for Developmental Biology and Stem Cell Research (NL)
  • Princess Máxima Center (NL)
  • Royal Netherlands Academy of Arts and Sciences (NL)
Corresponding author
Clevers, Hans
ORCID
Venue
The EMBO Journal
Publisher
Springer Science and Business Media LLC
Published
2019-01-14
Volume
38
Issue
4
ISSN
  • 0261-4189 (ISSN-L)
  • 1460-2075
DOI
10.15252/embj.2018100300
PMC
PMC6376275
OpenAlex
W2799736418
Cited by
1,082
References
82
Citations by year
2026: 126 · 2025: 178 · 2024: 137 · 2023: 159 · 2022: 157 · 2021: 182 · 2020: 104 · 2019: 30
FWCI
86.42
Type
journal article
Language
en
Open access
Licence
Locations
  • The EMBO Journal (publishedVersion, cc-by-nc-nd)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Research Publications (Maastricht University) (publishedVersion, cc-by-nc-nd)
  • KNAW research portal (Royal Academy of Art and Sciences (KNAW)) (publishedVersion, other-oa)
  • KNAW Research Portal (The Royal Netherlands Academy of Arts and Sciences) (publishedVersion, other-oa)
  • AMOLF Institutional Repository (AMOLF) (submittedVersion, other-oa)
  • Data Archiving and Networked Services (DANS) (submittedVersion, cc-by-nc-nd)
  • Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
  • Research Publications (Maastricht University) (submittedVersion, cc-by-nc-nd)
  • Utrecht University Repository (Utrecht University) (submittedVersion, cc-by-nc-nd)
Funders
  • ZonMw (114021012, 40‐00812‐98‐14103, 91615182)
  • Human Frontier Science Program (CDA00076/2014‐C)
  • Prof. Dr. Jaap Swieringa Foundation (stAH‐CvM‐HI‐HC)
  • Dutch Cystic Fibrosis Society (HIT‐CF)
  • SU2C (SU2C‐AACR‐DT‐12‐14)
  • KWF Kankerbestrijding (2014‐7006)
  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek (680‐47‐529, 834.11.002)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Neonatal Respiratory Health Research
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
Keywords
airway organoids, cystic fibrosis, CFTR function, lung cancer, metastasis, respiratory syncytial virus, NS2 protein, neutrophil recruitment, disease modeling, Clara cells, ciliated cells
MeSH terms
Animals, Carcinoma, Non-Small-Cell Lung, Cells, Cultured, Cystic Fibrosis, Disease Models, Animal, Drug Screening Assays, Antitumor, Epithelial Cells, Female, Humans, Lung Neoplasms, Male, Organ Culture Techniques, Organoids, Respiratory Syncytial Viruses, Respiratory System, Mice, SCID, Mice, Inbred NOD, Respiratory Syncytial Virus Infections, Cystic Fibrosis Transmembrane Conductance Regulator, Xenograft Model Antitumor Assays, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review